Abstract
Previous studies have shown that antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) can be divided into two types on the basis of their functional activity. One type is able to mediate opsonic killing in conjunction with leukocytes and complement, and the other type is not. We investigated, in mice, the properties of this antigen associated with elicitation of opsonic killing antibody. We found that smaller-sized material (Kav = 0.26), which has been tested as a human vaccine, elicited opsonic killing antibody in mice at low doses (1 to 10 micrograms) and at doses of greater than or equal to 40 micrograms, only nonopsonic killing antibody was produced. A similar dose effect was seen with heat-killed mucoid P. aeruginosa cells. After immunization with high doses of this MEP or the heat-killed cells, the mice were refractory to induction of opsonic killing antibody no matter what dose of MEP was used as a booster. In contrast, a larger-molecular-weight preparation (Kav = 0.05) elicited opsonic killing antibody over a wide dose range (1 to 400 micrograms). Additionally, 50 micrograms of the larger-sized preparation could overcome the suppression induced by 50 micrograms of the smaller material. Suppression elicited by 50 micrograms of the smaller material could be adoptively transferred to nonimmune mice with the T-cell fraction of spleen cells. These results indicate that both molecular size and dose are critical determinants for eliciting opsonic killing antibody to mucoid P. aeruginosa after immunizing with MEP.
MeSH Terms
Animals
Cytotoxicity, Immunologic
Dose-Response Relationship, Immunologic
Glycosaminoglycans/immunology
Immune Tolerance
Immunization
Immunization, Passive
Mice
Molecular Weight
Phagocytosis
Polysaccharides, Bacterial/immunology
Pseudomonas aeruginosa/immunology
Chemicals
Glycosaminoglycans
Polysaccharides, Bacterial
mucoid exopolysaccharide (P aeruginosa)
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Garner C V
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
DesJardins D
Pier G B
References (20)
20 references, click to expand
-
A new modification of the carbazole analysis: application to heteropolysaccharides.
Anal Biochem. 1968 Sep;24(3):470-81
PMID: 5723302
-
The gamma delta T cell receptor.
Adv Immunol. 1988;43:133-92
PMID: 3055853
-
Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production.
J Med Microbiol. 1975 Nov;8(4):513-22
PMID: 812998
-
Cystic fibrosis.
Am Rev Respir Dis. 1976 Jun;113(6):833-78
PMID: 779549
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem. 1976 May 7;72:248-54
PMID: 942051
-
"Panning" for lymphocytes: a method for cell selection.
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844-8
PMID: 351618
-
Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells.
J Immunol. 1980 Oct;125(4):1849-54
PMID: 6157748
-
Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.
J Clin Invest. 1982 Feb;69(2):303-8
PMID: 6799548
-
Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
J Immunol. 1982 May;128(5):2121-5
PMID: 6174622
-
Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
J Infect Dis. 1983 Mar;147(3):494-503
PMID: 6220094
-
Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.
J Clin Microbiol. 1983 Aug;18(2):276-82
PMID: 6413528
-
Diagnosis and treatment of cystic fibrosis. An update.
Chest. 1984 Jun;85(6):802-9
PMID: 6373170
-
Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide.
Infect Immun. 1985 Aug;49(2):281-5
PMID: 3160660
-
Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
J Clin Microbiol. 1986 Aug;24(2):189-96
PMID: 2943759
-
Aeration selects for mucoid phenotype of Pseudomonas aeruginosa.
J Clin Microbiol. 1986 Dec;24(6):986-90
PMID: 3097070
-
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
N Engl J Med. 1987 Sep 24;317(13):793-8
PMID: 2957591
-
T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to Pseudomonas aeruginosa.
J Immunol. 1988 Apr 15;140(8):2746-52
PMID: 3128607
-
Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.
Infect Immun. 1988 Dec;56(12):3095-8
PMID: 2460407
-
Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells.
J Immunol. 1988 Dec 1;141(11):3975-9
PMID: 2460554
-
Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
J Immunol. 1974 Jun;112(6):2020-7
PMID: 4151107